A New Era of Immunotherapy in Small-Cell Lung Cancer

Watch this CME-certified video module of 2 lung cancer experts discussing recent advances in immunotherapy for the treatment of SCLC as they apply to a series of patient cases.
Anna F. Farago, MD, PhD
Leora Horn, MD, MSc, FRCPC
Released: August 8, 2019 Expiration: No longer available for credit

Related Content

On-demand Clinical Care Options (CCO) Webcast on corneal toxicity in patients receiving antibody-drug conjugate therapy for the treatment of cancer

Asim V. Farooq, MD
Program Director
Sagar Lonial, MD Anthony Perissinotti, PharmD, BCOP
Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: January 20, 2021 Expired: January 19, 2022

Downloadable slideset reviewing global perspectives on biomarker-driven therapeutic strategies for pancreatic cancer, from Clinical Care Options (CCO)

Philip Agop Philip, MD, PhD, FRCP Released: January 20, 2021

Brief expert video from Clinical Care Options (CCO) on recommended treatment strategies for anemia in patients with myelodysplastic syndrome (MDS)

Rami S. Komrokji, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: January 19, 2021 Expired: January 18, 2022

Brief expert video from Clinical Care Options (CCO) on recommended treatment strategies for patients with higher-risk myelodysplastic syndrome (MDS)

Rami S. Komrokji, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: January 19, 2021 Expired: January 18, 2022
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
Bristol-Myers Squibb
Genentech

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue